Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2005
10/05/2005CN1678314A Glycinamide derivatives as raf-kinase inhibitors
10/05/2005CN1678309A Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
10/05/2005CN1678307A Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors
10/05/2005CN1678299A Composition based on triethyl citrate for the treatment of bacterial infections of the skin
10/05/2005CN1678188A Nucleic acid compositions for stimulating immune responses
10/05/2005CN1676607A Cloning genes from streptomyces cyaneogriseus subsp. noncyanogenus for biosynthesis of antibiotics and methods of use
10/05/2005CN1676533A Gecko polysaccharide, and its preparing method and pharmaceutical use
10/05/2005CN1676529A Macrilides ketolide compound, and its preparing method and use
10/05/2005CN1676526A Substituted 2-benzoyl piperazine methyl penem compound, and its preparing method and use
10/05/2005CN1676162A Thymic penta peptide injection liquid
10/05/2005CN1676161A Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method
10/05/2005CN1676148A Chinese herbal medicine formula for treating hepatitis
10/05/2005CN1676140A Composition for treating hepatitis B and process for making same
10/05/2005CN1676135A Use of native silver for preparing antibacterial anti-inflammation, and element medicine and antiseptic
10/05/2005CN1676120A Method for preparing hard-soluble gel formulation
10/05/2005CN1221548C Oxazolidinones having sulfoximine functional group
10/05/2005CN1221544C Pyrazole cyclic AMP-specific PDE inhibitors
10/05/2005CN1221271C Chinese medicinal external preparation for treating ulcer of lower limbs
10/05/2005CN1221264C Medicine composition of local administration for treating herpes zoster
10/05/2005CN1221260C Use of oxidized matrine in preparation of medicine for treating venereal diseases
10/05/2005CN1221248C Preparation method for antibiotics composition
10/04/2005US6951916 Melanocortin receptor ligands
10/04/2005US6951885 Pharmaceutical composition
10/04/2005US6951879 Heteroaromate OSC inhibitors
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951848 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
10/04/2005US6951754 Expression vector for use as transformation and gene expression tool in genetic engineering
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951732 Virulence genes, proteins, and their use
10/04/2005US6951717 Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
10/04/2005US6951654 Intravaginal drug delivery devices for the administration of an antimicrobial agent
10/04/2005US6951653 Streptococcal C5a peptidase vaccine
10/04/2005US6951652 Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
10/04/2005US6951650 Antigenic class of avian reoviruses
10/04/2005US6951646 recognizing conformation dependent epitopes of HCV glycoprotein E2 that are capable of neutralizing the binding of E2 protein onto susceptible cells
10/04/2005US6951642 Water-in-oil emulsions with anionic groups, compositions, and methods
10/04/2005US6951219 Treatment of hepatitis C using hyperthermia
10/04/2005CA2104877C Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
09/2005
09/29/2005WO2005090576A1 Dna construct for preventing pertussis infection
09/29/2005WO2005090575A1 Glycosylation variants of ricin-like proteins
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005089802A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005WO2005089782A1 Process for producing fermented stevia solution, health drink for livestock and udder wasiing liquor for livestock
09/29/2005WO2005089781A1 Method of preventing nodavirus infection and therapeutic method
09/29/2005WO2005089780A1 Composition against aids virus and method of selectively inactivating virus-infected cells
09/29/2005WO2005089716A1 Preparation with elevated content
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005018556A3 Hydroxylamine substituted imidazo-containing compounds
09/29/2005WO2005016916A3 Substituted quinolines serving as antimicrobial agents
09/29/2005WO2005012360A3 Binding molecules against sars-coronavirus and uses thereof
09/29/2005WO2004089943A8 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
09/29/2005WO2004069196A3 Novel compounds
09/29/2005WO2004041758A8 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonistics
09/29/2005WO2003074057A8 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
09/29/2005US20050216958 Fucosyltransferase knock-out host cell for use as bioreactors in production of preferentially modified glycoproteins
09/29/2005US20050215772 Furanone derivatives and methods of making same
09/29/2005US20050215640 HMB compositions and uses thereof
09/29/2005US20050215639 Disinfectant with activity against hepatitis b virus
09/29/2005US20050215637 Tuberculosis treatment
09/29/2005US20050215627 Application of substances acting as cascade inhibitors of the Raf/MEK/ERK signaling cascade for the production of a drug against DNA and RNA viruses
09/29/2005US20050215613 with indazole or thienopyrazole compounds such as 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl-indazole
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215581 Administering the compound N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}morpholine-4-carboxamide inducing cytokine biosynthesis; Viricides; anticancer agents; immunology moderators
09/29/2005US20050215563 Proteomimetic compounds and methods
09/29/2005US20050215553 For therapy and prophylaxis of cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215549 TACE inhibitors
09/29/2005US20050215547 Optically active pyridine derivative and a medicament containing the same
09/29/2005US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia
09/29/2005US20050215533 Administering to mammal an effective amount of sulfaphenazole wherein the administered sulfaphenazole substantially reduces the amount of infracted tissue
09/29/2005US20050215520 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
09/29/2005US20050215497 Treating prostate cancer by administering double stranded oligonucleotide having two complementary oligonucleotide sequences forming a hybrid; each sequence has at one 3' or 5' end 1-5 unpaired nucleotides forming single-strand ends extending beyond the hybrid
09/29/2005US20050215495 Macrolide antibiotics
09/29/2005US20050215490 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent
09/29/2005US20050215477 Treating agonist disorderssuch asd diabetes, obesity, heart dysfunctions, AIDS-related wasting, and kidney, neurological, whole body growth disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern
09/29/2005US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins
09/29/2005US20050214378 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
09/29/2005US20050214364 Products and methods for treating vaginal infections
09/29/2005US20050214334 Composition for topical substance delivery
09/29/2005US20050214329 Vaccine
09/29/2005US20050214324 Culturing avian cells permissive for productive replication of the virus in a serum free medium containing a growth factor or an attachment factor, infecting of the cells with the virus, and cultivating in serum free media until progeny virus is produced
09/29/2005US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus
09/29/2005US20050214319 Peptides and DNA encoding peptides that carry novel cytotoxic T lymphocyte epitopes derived from fragments of human immunodeficiency virus-1 Pol or envelope proteins and carry HLA-A*1101 binding motif; vaccines
09/29/2005US20050214291 Treatment method
09/29/2005US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome
09/29/2005US20050214253 Interferon-beta fusion proteins and uses
09/29/2005US20050214247 Glycodendrimers having biological activity
09/29/2005DE10393402T5 Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen Means and Toilettenartikel- or pharmaceutical composition to accelerate the uptake of basic amino acids in cells
09/29/2005CA2562388A1 Emulsion-stabilized preparation
09/29/2005CA2560953A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
09/29/2005CA2560636A1 Glycosylation variants of ricin-like proteins
09/29/2005CA2560300A1 Method of preventing nodavirus infection and therapeutic method
09/29/2005CA2560298A1 Preparation with elevated content
09/29/2005CA2560253A1 Prodrugs of piperazine and substituted piperidine antiviral agents
09/29/2005CA2559969A1 Streptococcus agalactiae vaccine
1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 1798